BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 8991238)

  • 1. Serological evidence of Lyme borreliosis in Africa: results from studies in Dar es Salaam, Tanzania.
    Mhalu FS; Matre R
    East Afr Med J; 1996 Sep; 73(9):583-5. PubMed ID: 8991238
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development and laboratory evaluation of a new recombinant ELISA for the serodiagnosis of Lyme disease.
    Hunfeld KP; Ernst M; Zachary P; Jaulhac B; Sonneborn HH; Brade V
    Wien Klin Wochenschr; 2002 Jul; 114(13-14):580-5. PubMed ID: 12422605
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Borrelia burgdorferi (strain B. afzelii) antibodies among Malaysian blood donors and patients.
    Tay ST; Kamalanathan M; Rohani MY
    Southeast Asian J Trop Med Public Health; 2002 Dec; 33(4):787-93. PubMed ID: 12757227
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of different Borrelia burgdorferi sensu lato strains for detection of immune response in patients with erythema migrans.
    Merljak Skocir L; Ruzić-Sabljić E; Maraspin-Carman V; Lotric-Furlan S; Logar M; Strle F
    Int J Med Microbiol; 2008 Jul; 298(5-6):493-504. PubMed ID: 17892971
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Comparison of test with antigen VlsE (C6) with tests with recombinant antigens in patients with Lyme borreliosis].
    Zajkowska JM; Kondrusik M; Pancewicz SA; Grygorczuk S; Jamiołkowski J; Stalewska J
    Pol Merkur Lekarski; 2007 Aug; 23(134):95-9. PubMed ID: 18044336
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The outcome of Lyme borreliosis in children.
    Aberer E; Kehldorfer M; Binder B; Schauperi H
    Wien Klin Wochenschr; 1999 Dec; 111(22-23):941-4. PubMed ID: 10666805
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Correlation of tests for detection of Borrelia burgdorferi sensu lato infection in patients with diagnosed borreliosis.
    Chmielewska-Badora J; Cisak E; Wójcik-Fatla A; Zwoliński J; Buczek A; Dutkiewicz J
    Ann Agric Environ Med; 2006; 13(2):307-11. PubMed ID: 17196006
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Persistence of immunoglobulin M or immunoglobulin G antibody responses to Borrelia burgdorferi 10-20 years after active Lyme disease.
    Kalish RA; McHugh G; Granquist J; Shea B; Ruthazer R; Steere AC
    Clin Infect Dis; 2001 Sep; 33(6):780-5. PubMed ID: 11512082
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Seasonal prevalence of antibodies against Borrelia burgdorferi in Białowieza inhabitants.
    Flisiak R; Wiercińska-Drapało A; Kalinowska A; Prokopowicz D
    Rocz Akad Med Bialymst; 1996; 41(1):96-102. PubMed ID: 8673812
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The prevalence of antibodies against B. burgdorferi, an indicator for Lyme borreliosis in dogs? A comparison of serological tests.
    Goossens HA; Maes JH; van den Bogaard AE
    Tijdschr Diergeneeskd; 2003 Nov; 128(21):650-7. PubMed ID: 14650723
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serodiagnosis of Lyme borreliosis using detection of different immunoglobulin (sub)classes by enzyme-linked immunosorbent assay and Western blotting.
    Goossens HA; van den Bogaard AE; Nohlmans MK
    Clin Lab; 2001; 47(1-2):41-9. PubMed ID: 11214222
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immune responses to borrelial VlsE IR6 peptide variants.
    Sillanpää H; Lahdenne P; Sarvas H; Arnez M; Steere A; Peltomaa M; Seppälä I
    Int J Med Microbiol; 2007 Feb; 297(1):45-52. PubMed ID: 17234451
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lyme disease seroprevalence in a region of central Italy.
    Santino I; Nicosia R; Sessa R; Pustorino R; Pastorelli D; Isacchi G; Del Piano M
    New Microbiol; 1995 Oct; 18(4):391-8. PubMed ID: 8590392
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Prevalence of Borrelia burgdorferi antibodies in healthy population in Poland].
    Chmielewski T; Tylewska-Wierzbanowska S
    Przegl Epidemiol; 2002; 56(1):33-8. PubMed ID: 12150065
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Lyme disease in the province of Soria: clinico-epidemiologic study].
    Saz JV; Nuncio S; Merino FJ; Aquise M; Medina J; Filipe AR
    Enferm Infecc Microbiol Clin; 1994 Feb; 12(2):52-9. PubMed ID: 8011711
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Seroepidemiologic study on Lyme borreliosis in the Lublin region.
    Chmielewska-Badora J
    Ann Agric Environ Med; 1998; 5(2):183-6. PubMed ID: 9860821
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk of tick-borne bacterial diseases among workers of Roztocze National Park (south-eastern Poland).
    Cisak E; Chmielewska-Badora J; Zwoliński J; Wójcik-Fatla A; Polak J; Dutkiewicz J
    Ann Agric Environ Med; 2005; 12(1):127-32. PubMed ID: 16028877
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Erythema migrans and serodiagnosis by enzyme immunoassay and immunoblot with three borrelia species.
    Stanek G; Breier F; Menzinger G; Schaar B; Hafner M; Partsch H
    Wien Klin Wochenschr; 1999 Dec; 111(22-23):951-6. PubMed ID: 10666807
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Lyme disease in Tunisia, results of a clinical and serological study (1992-1996)].
    Aoun K; Kechrid A; Lagha N; Zarrouk A; Bouzouaia N
    Sante; 1998; 8(2):98-100. PubMed ID: 9642728
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Informational value of the prevalence of antiborrelia antibodies in a healthy and at risk population].
    Bartůnĕk P; Mrázek V; Varejka P; Sklenár T; Bína R; Listvanová S; Janovská D
    Epidemiol Mikrobiol Imunol; 2000 Feb; 49(1):4-10. PubMed ID: 10802944
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.